Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), derived from the native 44-amino-acid GHRH sequence and modified at its N-terminus. It is supplied for controlled laboratory and analytical research involving peptide identity, molecular structure, and receptor-interaction studies.
Research Context
Tesamorelin is studied as a defined GHRH analog. Its structural modification is used in research that compares peptide stability and receptor-interaction characteristics with unmodified GHRH and other experimental compounds.
Laboratory Research Information
Laboratory studies may examine molecular characterization, sequence relationships, analytical identification, receptor-binding models, and experimental assay behavior. Observations should be interpreted within the design and limitations of the relevant study.
Specifications
| Chemical Name | Tesamorelin |
| Compound Type | GHRH analog |
| Research Target | GHRH receptor |
| Molecular Weight | 5132.72 Da (monoisotopic) |
| PubChem CID | 16137828 |
| Available Sizes | 10 mg, 20 mg |
| Purity | 99.82% (20 mg lot) |
| Testing Method | HPLC-UV-MS |
| Laboratory | MZ Biolabs |
For laboratory research use only. Not for human or veterinary use. This material does not provide medical or consumer-use guidance.
